MIRM icon

Mirum Pharmaceuticals
MIRM

Overview Fund Activity

145 hedge funds and large institutions have $956M invested in Mirum Pharmaceuticals in 2023 Q2 according to their latest regulatory filings, with 38 funds opening new positions, 58 increasing their positions, 28 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
145
Holders Change
+29
Holders Change %
+25%
% of All Funds
2.29%
Holding in Top 10
9
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+50%
% of All Funds
0.14%
New
38
Increased
58
Reduced
28
Closed
9
Calls
$486K
Puts
$1.33M
Net Calls
-$846K
Net Calls Change
-$11.1M

Top Buyers

1
EAM
1
Eventide Asset Management
Massachusetts
$89.5M
2
NIP
2
Nicholas Investment Partners
California
$23.7M
3
CCM
3
Cadian Capital Management
New York
$32.7M
4
FLSM
4
Frazier Life Sciences Management
California
$113M
5
William Blair Investment Management
5
William Blair Investment Management
Illinois
$8.73M

Top Sellers

1
NMC
1
NEA Management Company
Maryland
$56.6M
2
DM
2
Deerfield Management
New York
$0
3
Axa
3
Axa
France
$17.3M
4
WP
4
Woodline Partners
California
$8.48M
5
Wellington Management Group
5
Wellington Management Group
Massachusetts
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
VFA
151
Values First Advisors
Tennessee
– -$204K -8,497 Closed
BAM
152
Belpointe Asset Management
Nevada
– -$67.3K -2,800 Closed
3 4 5 6
7